| Literature DB >> 15203917 |
Daniela S Pontes1, Fernanda A Dorella, Luciana A Ribeiro, Anderson Miyoshi, Yves Le Loir, Alexandra Gruss, Sérgio C Oliveira, Philippe Langella, Vasco Azevedo.
Abstract
The Brucella abortus ribosomal protein L7/L12 is an immunodominant antigen and an interesting candidate for the development of oral live vaccines against brucellosis. Here, a recombinant Lactococcus lactis strain producing L7/L12 under the control of nisin inducible promoter was orally administered to BALB/c mice. Significant levels of anti-L7/L12 specific IgA detected in feces revealed an induced local humoral immune response. However, serum analysis did not reveal any anti-L7/L12 antibodies suggesting the absence of a systemic response. Nevertheless, the vaccinated mice showed a partial protective immunity against B. abortus virulent strain (S2308) challenged by intraperitoneal inoculation.Entities:
Mesh:
Substances:
Year: 2003 PMID: 15203917 DOI: 10.1080/10611860410001670035
Source DB: PubMed Journal: J Drug Target ISSN: 1026-7158 Impact factor: 5.121